# Alvotech (ALVO) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/ALVO
## Company Profile
- Ticker: ALVO
- Exchange: NASDAQ
- Sector: Biopharma
- Location: Iceland
- Tags: Biologics, Generics
## Stock Data
- Close: 5.38 USD
- Market cap: 936144876 USD
- Last updated: 2026-09-03
## Business Overview
Alvotech is a biosimilars company developing and manufacturing lower-cost alternatives to complex biologic medicines.
## Why The Stock Is Moving

As of Sep 3, 2026, ALVO closed up 0.75% at $5.38. No new same-company headline was identified in the current news window.

## Geographic Base

Headquartered in Iceland and listed on NASDAQ, Alvotech has a global biosimilar footprint.

## Business Model

The company relies on manufacturing execution, regulatory approvals, and commercial launches across biosimilar markets.

## Landscape Position

Alvotech sits in the biosimilar segment where scale, regulatory success, and manufacturing discipline matter most.

## Future Catalysts

- Alvotech's catalysts are biosimilar launches, partner rollouts, and any approval that helps the company keep scaling its complex-antibody portfolio. The business is all about execution across multiple biosimilar assets.

## Recent News
- 2026-08-31 08:30 EST — [Matvæla- og lyfjastofnun Bandaríkjanna (FDA) tekur til afgreiðslu umsókn Alvotech um markaðsleyfi fyrir fyrirhugaða hliðstæðu við Entyvio í sprautu eða lyfjapenna](https://biopharmsignal.com/news/ALVO/matv-la-og-lyfjastofnun-bandar-kjanna-fda-tekur-til-afgrei-slu-ums-kn-alvotech-u-77ce200e) — Source: Alvotech
- 2026-08-31 08:30 EST — [Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio® to subcutaneous presentations](https://biopharmsignal.com/news/ALVO/alvotech-announces-fda-acceptance-for-review-of-biologics-license-application-fo-e9b4232d) — Source: Alvotech
- 2026-08-27 12:00 EST — [Alvotech tekur þátt í ráðstefnum fyrir fjárfesta í september](https://biopharmsignal.com/news/ALVO/alvotech-tekur-tt-r-stefnum-fyrir-fj-rfesta-september-d70fb244) — Source: Alvotech
- 2026-08-27 12:00 EST — [Alvotech to present at upcoming investor conferences in September](https://biopharmsignal.com/news/ALVO/alvotech-to-present-at-upcoming-investor-conferences-in-september-6db07c4b) — Source: Alvotech
- 2026-08-21 13:00 EST — [Alvotech kynnir samning við Lotus Pharmaceutical um markaðssetningu á fyrirhuguðum hliðstæðum við durvalumab og emicizumab í Bandaríkjunum og á völdum mörkuðum í Asíu](https://biopharmsignal.com/news/ALVO/alvotech-kynnir-samning-vi-lotus-pharmaceutical-um-marka-ssetningu-fyrirhugu-um--6c472154) — Source: Alvotech